Category: Cardiovascular
Global Cardiovascular
-
Stroke Management
... at a CAGR of 5.4% over the analysis period 2023-2030. Stroke Management Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$35.9 Billion by the end ... Read More
-
Critical Care Therapeutics
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Albumin Drug Class, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion ... Read More
-
C-Reactive Protein Testing
... by 2030, growing at a CAGR of 1.8% over the analysis period 2023-2030. C-Reactive Protein Testing for Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and ... Read More
-
Global Pediatric Home Healthcare Market Size Study, by Services (Skilled Nursing Services, Personal Care Assistance, Rehabilitation Therapy Services), by Application (Cancer, Respiratory Disease, Cardiovascular Disease, Physical Disabilities, Others), and Regional Forecasts 2022-2032
... Healthcare Market is valued at USD 39.69 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2024-2032. Pediatric home healthcare is a comprehensive, ... Read More
-
Global Predictive Presymptomatic Testing Market 2024-2028
... forecast period. The report on the predictive presymptomatic testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Drug-Coated Balloons Market - Focused Insights 2024-2029
... with DCB The growing burden of cardiovascular diseases is accelerating the continued development of interventional cardiology and has led to the development of drug-coated balloons. Traditional metallic stents represent several limitations in interventional cardiology, where ... Read More
-
Global Peripheral Artery Disease Market Size Study, by Product Type (Devices, Drugs), by End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers), and Regional Forecasts 2022-2032
... 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032. Peripheral artery disease (PAD) is characterized by the narrowing or blockage of ... Read More
-
Global Cardiac Biomarkers Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 1310.7 million by 2030 with a CAGR of 8.8% during review period. Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally ... Read More
-
Global Acute Rehabilitation Market Size Study, by Phase Type (Phase I- Acute Phase, Phase II- Subacute Phase, Phase III- Intensive Outpatient Therapy, Phase IV- Independent Ongoing Conditioning), by Devices Product (Blood Pressure Monitor, Heart Rate Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure or Transplant, High Blood Pressure, Pulmonary Hypertension), by End User (Home Care, Hospitals & Clinics, Rehabilitation Centers, Specialty Centers), and Regional Forecasts 2022-2032
... Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure ... Read More
-
Global Diuretic Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Statin Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Cholesterol Testing
... at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Atrial Fibrillation Devices
... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. EP Ablation Catheters, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$4.8 Billion ... Read More
-
Cardiology IT Workflow Solutions
... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Cardiovascular Catheters
... at a CAGR of 6.5% over the analysis period 2023-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.4 Billion by the end ... Read More
-
Carotid Stents
... at a CAGR of 8.7% over the analysis period 2023-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$4.3 Billion by the end ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
Cardiovascular Drugs
... at a CAGR of 3.5% over the analysis period 2023-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$57.7 Billion by the end of the ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Dyslipidemia - Global Clinical Trials Review, 2024
... report provides top line data relating to the clinical trials on Dyslipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of ... Read More
-
Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestional, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
... projected to reach USD 49.9 Billion by 2029 from USD 31.7 Billion in 2024, at a CAGR of 9.5% during the forecast period. Market expansion is propelled by factors such as the growing utilization of ... Read More
-
2024 Global: Myocardial Fibrosis Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Atherosclerosis Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
Research Assistance
